title: Myocardial infarction and type II diabetes--preferential treatment for high risk patients?
abstract: OBJECTIVE
  To compare variability of blood glucose concentration in patients with type II diabetes with (cases) and without (controls) myocardial infarction. A secondary objective was identification of predictive factors for higher blood glucose on discharge from hospital.
  
  
  METHODS
  A retrospective matched case-control study.
  
  
  METHODS
  Medical notes of 101 type II diabetic patients admitted with a myocardial infarction (MI) and 101 type II diabetic patients (controls) matched on gender and age with no MI were reviewed. Blood glucose concentrations over two consecutive 48-h periods were collected. Demographic data and therapy on admission/discharge were also collected.
  
  
  RESULTS
  Patient characteristics were comparable on recruitment excluding family history of cardiovascular disease (P=0.003), dyslipidaemia (P=0.004) and previous history of MI (P=0.007). Variability of blood glucose in cases was greater over the first 48 h compared with the second 48 h (P=0.03), and greater when compared with controls over the first 48 h (P=0.01). Cases with blood glucose on discharge >8.2 mmol / L (n=45) were less likely to have a history of previous MI (P=0.04), ischaemic heart disease (P=0.03) or hypertension (P=0.02).
  
  
  CONCLUSIONS
  Type II diabetics with an MI have higher and more variable blood glucose concentrations during the first 48 h of admission. Only cardiovascular 'high risk' patients had target blood glucose set on discharge. The desirability of all MI patients with diabetes, having standardized-glucose infusions to reduce variability of blood glucose, should be evaluated in a randomized controlled trial.
authors.affiliation: Department of Pharmacy, Royal Brisbane Hospital, Brisbane, Queensland, Australia. greenb@pharmacy.uq.edu.au
authors.forename: B
authors.initials: B
authors.lastname: Green
authors.forename: S
authors.initials: S
authors.lastname: Duffull
authors.forename: N
authors.initials: N
authors.lastname: Cottrell
authors.forename: M
authors.initials: M
authors.lastname: D'Emden
mesh_terms: D000368:Aged; D001786:Blood Glucose / Q000032:analysis*; D016022:Case-Control Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000150:complications*; D005260:Female; D006801:Humans; D008297:Male; D009203:Myocardial Infarction / Q000097:blood / Q000150:complications*; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors
chemical_list: D001786:Blood Glucose